Alumis Inc. (ALMS) vs SI-BONE, Inc. (SIBN)
A side-by-side comparison of Alumis Inc. and SI-BONE, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALMS
Alumis Inc.
$6.77HealthcareDelayed quote: Oct 6, 2026, 3:20 PM EDT
SIBN
SI-BONE, Inc.
$19.34HealthcareDelayed quote: Oct 6, 2026, 3:15 PM EDT
Total return — ALMS vs SIBN
growth of $100 · dividends reinvested · last 2yALMS -48.6% (-28.3%/yr)SIBN +59.4% (+26.2%/yr)SIBN compounded faster over this window
ALMS SIBN
ALMS vs SIBN: by the numbers
- •SIBN is the larger company ($858M vs $835M market cap).
- •Both run net losses; SIBN's is the smaller (-6.85% vs -5933.45% net margin).
Metrics side by side
Valuation
| Metric | ALMS | SIBN |
|---|---|---|
| P/S ratio | 112.89 | 4.01 |
| P/B ratio | 1.85 | 4.70 |
Profitability
| Metric | ALMS | SIBN |
|---|---|---|
| Gross margin | 88.23% | 79.53% |
| Operating margin | -1776.32% | -8.31% |
| Net margin | -5933.45% | -6.85% |
| ROE | -97.08% | -8.03% |
| ROIC | -94.76% | -7.88% |
Growth (annualized)
| Metric | ALMS | SIBN |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 20.20% |
| Total return CAGR (5Y) | N/A | -1.46% |
Go deeper
Dig into the metrics
Alumis ROESI-BONE ROEAlumis operating marginSI-BONE operating marginAlumis revenue growthSI-BONE revenue growthAlumis free cash flowSI-BONE free cash flow
Alumis & SI-BONE appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.